The interaction of pemphigus autoimmunoglobulins with epidermal cells: Activation of the Fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients

Annals of the New York Academy of Sciences

Volumn 1050, Issue , 2005, Pages 371-379

  Frušić Zlotkin, Marina ^a   Pergamentz, Rochel ^a   Michel, Beno ^b   David, Michael ^c   Mimouni, Daniel ^c   Brégégère, François ^a   Milner, Yoram ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Michel Skin Care Incorporated   (United States)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

Acantholysis; Apoptosis; Autoimmunity; Pemphigus IgG

Indexed keywords

AUTOANTIBODY; CASPASE; CASPASE 8; DESMOGLEIN 1; DESMOGLEIN 3; FAS ANTIGEN;

ACANTHOLYSIS; APOPTOSIS; AUTOIMMUNE DISEASE; BLISTER; CELL CULTURE; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; CYTOCHEMISTRY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIDERMIS CELL; FATALITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KERATINOCYTE; MITOCHONDRION; PATHOGENESIS; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; SKIN MANIFESTATION; UPREGULATION; WESTERN BLOTTING;

EID: 23744453295     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1313.040     Document Type: Conference Paper

References (20)

1. WANG, X.F. et al. 2004. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis 9: 131-143.
2. UDEY, M.C. & J.R. STANLEY. 1999. Pemphigus-diseases of antidesmosomal autoimmunity. JAMA 282: 572-576.
3. STANLEY, J.R. 1997. Update: structure and function of pemphigus vulgaris antigen. J. Dermatol. 24: 741-743.
4. PAYNE, A.S. et al. 2004. Desmosomes and disease: pemphigus and bullous impetigo. Curr. Opin. Cell Biol. 16: 536-543.
5. LO MUZIO, L. et al. 2002. Strict correlation between uPAR and plakoglobin expression in pemphigus vulgaris. J. Cutan. Pathol. 29: 540-548.
6. MAHONEY, M.G., Z.H. WANG & J.R. STANLEY. 1999. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J. Invest. Dermatol. 113: 22-25.
7. ESAKI, C. et al. 1995. Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. J. Invest. Dermatol. 105: 329-333.
8. MILNER, Y. et al. 1999. Pemphigus - an autoimmune disease of the skin: cell-cell separation versus membranal signaling and apoptosis in acantholysis. In The Decade of Autoimmunity, pp. 197-207. Elsevier Science. Amsterdam/New York.
9. SANCHEZ-CARPINTERO, I. et al. 2004. In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades. Br. J. Dermatol. 151: 565-570.
10. AMAGAI, M. et al. 2000. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat. Med. 6: 1275-1277.
11. AOYAMA, Y., M.K. OWADA & Y.A. KITAJIMA. 1999. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur. J. Immunol. 29: 2233-2240.
12. NGUYEN, V.T. et al. 2004. Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes. J. Biol. Chem. 279: 2135-2146.
13. DIAZ, L.A. & C.L. MARCELO. 1978. Pemphigoid and pemphigus antigens in cultured epidermal cells. Br. J. Dermatol. 98: 631-637.
14. SCHILTZ, J.R. & B. MICHEL. 1976. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J. Invest. Dermatol. 67: 254-260.
15. ANHALT, G.J. et al. 1982. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N. Engl. J. Med. 306: 1189-1196.
16. WEISSMAN, V. et al. 1978. The correlation between the antibody titers in sera of patients with pemphigus vulgaris and their clinical state. J. Invest. Dermatol. 71: 107-109.
17. CRESWELL, S.N. et al. 1981. Correlation of circulating intercellular antibody titres in pemphigus with disease activity. Clin. Exp. Dermatol. 6: 477-483.
18. FITZPATRICK, R.E. & V.D. NEWCOMER. 1980. The correlation of disease activity and antibody titers in pemphigus. Arch. Dermatol. 116: 285-290.
19. ISHH, K. et al. 1997. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J. Immunol. 159: 2010-2017.
20. D'AGOSTO, G. et al. 2004. Evaluation of recombinant antigen-based assays for diagnosis of bullous autoimmune diseases. Clin. Diagn. Lab. Immunol. 11: 762-765.